SuperworthFulgent Genetics market cap FLGT
Share price times shares outstanding: what the whole company sells for, since 2016.
- Today, Oct 23, 2026
- $553.1M
- Highest close in our data
- $3.9B
- Feb 2021
Fulgent Genetics is worth $553.1M at the close on Oct 23, 2026, at $20.10 a share.
That is down 24% over the last year and down 77% over five years.
Its highest close in our data was $3.9B in Feb 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $553.1M | $401.3M | $868M | −33% |
| 2025 | $826M | $476.3M | $927.4M | +47% |
| 2024 | $561.9M | $529.5M | $835.1M | −34% |
| 2023 | $856.7M | $719.1M | $1.2B | −2% |
| 2022 | $876.7M | $876.7M | $2.4B | −71% |
| 2021 | $3B | $1.5B | $3.9B | +137% |
| 2020 | $1.3B | $184.2M | $1.3B | +411% |
| 2019 | $247.7M | $67.8M | $296M | +295% |
| 2018 | $62.7M | $57.1M | $92.3M | −20% |
| 2017 | $78.1M | $58.1M | $241.6M | −62% |
| 2016 | $204.5M | $150.2M | $204.5M | n/a |
Against its peers
Companies in Medical - Diagnostics & Research nearest Fulgent Genetics' size, closest first, today.
| Company | Market cap |
|---|---|
| FLGTFulgent Genetics | $553.1M |
| NRCNRC Health | $485.1M |
| ICCCImmucell | $93.1M |
| CDNACareDx | $3.6B |
| VCYTVeracyte | $3.9B |
| BLLNBillionToOne | $5.1B |
| Peer median | $3.6B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Fulgent Genetics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.